Mohamed Sherif

3.4k total citations
24 papers, 908 citations indexed

About

Mohamed Sherif is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Mohamed Sherif has authored 24 papers receiving a total of 908 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 6 papers in Cellular and Molecular Neuroscience and 5 papers in Psychiatry and Mental health. Recurrent topics in Mohamed Sherif's work include Neuroscience and Neuropharmacology Research (6 papers), Cannabis and Cannabinoid Research (5 papers) and Bipolar Disorder and Treatment (4 papers). Mohamed Sherif is often cited by papers focused on Neuroscience and Neuropharmacology Research (6 papers), Cannabis and Cannabinoid Research (5 papers) and Bipolar Disorder and Treatment (4 papers). Mohamed Sherif collaborates with scholars based in United States, Egypt and United Kingdom. Mohamed Sherif's co-authors include Deepak Cyril D’Souza, Mohini Ranganathan, Rajiv Radhakrishnan, John D. Cahill, William W. Lytton, Samuel A. Neymotin, Diego Contreras, Leif H. Finkel, Maciej T. Lazarewicz and Cathy Davies and has published in prestigious journals such as Journal of Neuroscience, Biological Psychiatry and Cochrane Database of Systematic Reviews.

In The Last Decade

Mohamed Sherif

23 papers receiving 895 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohamed Sherif United States 15 477 323 220 156 126 24 908
Frederico Rogério Ferreira Brazil 18 321 0.7× 306 0.9× 126 0.6× 190 1.2× 115 0.9× 35 1.0k
Jose Cortes-Briones United States 16 538 1.1× 366 1.1× 241 1.1× 65 0.4× 120 1.0× 26 810
Esther Blessing United States 17 433 0.9× 236 0.7× 415 1.9× 107 0.7× 165 1.3× 33 1.4k
Mónica Méndez‐Díaz Mexico 19 578 1.2× 415 1.3× 366 1.7× 68 0.4× 49 0.4× 76 1.2k
J.A.S. Crippa Brazil 13 517 1.1× 246 0.8× 226 1.0× 41 0.3× 163 1.3× 24 927
Christine Cloak United States 20 264 0.6× 448 1.4× 312 1.4× 80 0.5× 175 1.4× 39 1.3k
Kristin L. Bigos United States 15 256 0.5× 177 0.5× 218 1.0× 68 0.4× 356 2.8× 26 1.1k
Merja Viikki Finland 20 206 0.4× 155 0.5× 61 0.3× 211 1.4× 300 2.4× 45 1.1k
Jessica Hawkins United States 11 347 0.7× 158 0.5× 71 0.3× 253 1.6× 71 0.6× 19 610
Jeanne M. Manubay United States 21 164 0.3× 275 0.9× 61 0.3× 86 0.6× 73 0.6× 32 852

Countries citing papers authored by Mohamed Sherif

Since Specialization
Citations

This map shows the geographic impact of Mohamed Sherif's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohamed Sherif with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohamed Sherif more than expected).

Fields of papers citing papers by Mohamed Sherif

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohamed Sherif. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohamed Sherif. The network helps show where Mohamed Sherif may publish in the future.

Co-authorship network of co-authors of Mohamed Sherif

This figure shows the co-authorship network connecting the top 25 collaborators of Mohamed Sherif. A scholar is included among the top collaborators of Mohamed Sherif based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohamed Sherif. Mohamed Sherif is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sherif, Mohamed, et al.. (2025). Gut Microbiota Secondary Metabolites: Key Roles in GI Tract Cancers and Infectious Diseases. Biomedicines. 13(1). 100–100. 10 indexed citations
2.
Andrews, N.L., Wael F. Asaad, Mohamed Sherif, et al.. (2024). Prevalence of clinical electroencephalography findings in stroke patients with delirium. Clinical Neurophysiology. 162. 229–234. 3 indexed citations
3.
Sherif, Mohamed, et al.. (2023). Safety, feasibility, and quality of thulium laser en-bloc resection for treatment of non-muscle invasive bladder cancer. International Urology and Nephrology. 55(12). 3103–3109. 3 indexed citations
4.
Averill, Lynnette A., Christopher L. Averill, Ralitza Gueorguieva, et al.. (2022). mTORC1 inhibitor effects on rapid ketamine-induced reductions in suicidal ideation in patients with treatment-resistant depression. Journal of Affective Disorders. 303. 91–97. 26 indexed citations
5.
Gold, Michael, et al.. (2022). Large-scale EEG neural network changes in response to therapeutic TMS. Brain stimulation. 15(2). 316–325. 18 indexed citations
6.
Sherif, Mohamed, et al.. (2021). Evaluation of the Effect of Fluoride Application on Periodontal Health during Orthodontic Treatment (A Clinical Study). Al-Azhar Dental Journal for Girls. 8(1). 157–167. 1 indexed citations
7.
Abdallah, Chadi G., Lynnette A. Averill, Ralitza Gueorguieva, et al.. (2020). Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin. Neuropsychopharmacology. 45(6). 990–997. 127 indexed citations
8.
Yanni, Fady, et al.. (2020). Length of Barrett’s esophagus in the presence of low-grade dysplasia, high-grade dysplasia, and adenocarcinoma. Surgical Endoscopy. 35(8). 4756–4762. 10 indexed citations
9.
Sherif, Mohamed, et al.. (2019). Comparative Evaluation of the Antibacterial Effect of Triple Antibiotic Paste Vesus Propolis as Intracanal Medicament. Al-Azhar Dental Journal for Girls. 7(1). 1–6. 1 indexed citations
10.
11.
Aquino, João P. De, Mohamed Sherif, Rajiv Radhakrishnan, et al.. (2018). The Psychiatric Consequences of Cannabinoids. Clinical Therapeutics. 40(9). 1448–1456. 46 indexed citations
12.
Radwan, Rami, et al.. (2018). A Retrospective and Prospective Study to Develop a Pre-operative Difficulty Score for Laparoscopic Cholecystectomy. Journal of Gastrointestinal Surgery. 23(4). 690–695. 9 indexed citations
13.
D’Souza, Deepak Cyril, Rajiv Radhakrishnan, Mohamed Sherif, et al.. (2017). Cannabinoids and Psychosis. Current Pharmaceutical Design. 22(42). 6380–6391. 30 indexed citations
14.
Murray, Robin, Amir Englund, Anissa Abi‐Dargham, et al.. (2017). Cannabis-associated psychosis: Neural substrate and clinical impact. Neuropharmacology. 124. 89–104. 123 indexed citations
15.
Lytton, William W., Jeff Arle, Georgiy Bobashev, et al.. (2017). Multiscale modeling in the clinic: diseases of the brain and nervous system. Brain Informatics. 4(4). 219–230. 28 indexed citations
16.
Ranganathan, Mohini, Nicholas DeMartinis, Martin M. Bednar, et al.. (2017). Attenuation of ketamine-induced impairment in verbal learning and memory in healthy volunteers by the AMPA receptor potentiator PF-04958242. Molecular Psychiatry. 22(11). 1633–1640. 40 indexed citations
17.
Sherif, Mohamed, Rajiv Radhakrishnan, Deepak Cyril D’Souza, & Mohini Ranganathan. (2016). Human Laboratory Studies on Cannabinoids and Psychosis. Biological Psychiatry. 79(7). 526–538. 91 indexed citations
18.
Gopaluni, Seerapani, et al.. (2016). Interventions for chronic kidney disease-associated restless legs syndrome. Cochrane Database of Systematic Reviews. 2016(11). CD010690–CD010690. 41 indexed citations
19.
Preece, Ryan, et al.. (2015). Peer-assisted teaching of basic surgical skills. Medical Education Online. 20(1). 27579–27579. 43 indexed citations
20.
Neymotin, Samuel A., Maciej T. Lazarewicz, Mohamed Sherif, et al.. (2011). Ketamine Disrupts Theta Modulation of Gamma in a Computer Model of Hippocampus. Journal of Neuroscience. 31(32). 11733–11743. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frederico Rogério Ferreira Breakdown of academic impact, for papers by Jose Cortes-Briones Breakdown of academic impact, for papers by Esther Blessing Breakdown of academic impact, for papers by Mónica Méndez‐Díaz Breakdown of academic impact, for papers by J.A.S. Crippa Breakdown of academic impact, for papers by Christine Cloak Breakdown of academic impact, for papers by Kristin L. Bigos Breakdown of academic impact, for papers by Merja Viikki Breakdown of academic impact, for papers by Jessica Hawkins Breakdown of academic impact, for papers by Jeanne M. Manubay
Rankless by CCL
2026